Using intravitreal bevacizumab (Avastin^®) - Indian Scenario

Indian J Ophthalmol. 2017 Jul;65(7):545-548. doi: 10.4103/ijo.IJO_431_17.

Authors

Atul Kumar¹, Raghav Ravani¹

Affiliation

¹ Dr. Rajendra Prasad Centre for Ophthalmic Sciences, All India Institute of Medical Sciences, New Delhi, India.

No abstract available

Publication types

Editorial

MeSH terms

Angiogenesis Inhibitors / administration & dosage
Angiogenesis Inhibitors / adverse effects
Bevacizumab / administration & dosage
Bevacizumab / adverse effects*
Endophthalmitis* / diagnosis
Endophthalmitis* / epidemiology
Endophthalmitis* / etiology
Humans
Incidence
India / epidemiology
Intravitreal Injections / adverse effects
Receptors, Vascular Endothelial Growth Factor / antagonists & inhibitors
Retinal Diseases / drug therapy*

Substances

Angiogenesis Inhibitors
Bevacizumab
Receptors, Vascular Endothelial Growth Factor